Bruno Mégarbane

Prof. Bruno Mégarbane

Department of Medical and Toxicological Critical Care, Lariboisière Hospital, INSERM UMRS-1144, Paris-University, 75010 Paris, France
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2014 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
PAPierre Asfar
Pierre Asfar
FMFerhat Meziani
Ferhat Meziani
JHJean-François Hamel
Jean-François Hamel
FGFabien Grelon
Fabien Grelon
Bruno MégarbaneBruno Mégarbane
Bruno Mégarbane
PRPeter Radermacher
Peter Radermacher
The Surviving Sepsis Campaign recommends targeting a mean arterial pressure of at least 65 mm Hg during initial resuscitation of patients with septic shock. However, whether this blood-pressure target is more or less effective than a higher target is unknown.

1 February 2007 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
ALAlexandre Lautrette
Alexandre Lautrette
Michel DARMONMichel DARMON
Michel DARMON
Bruno MégarbaneBruno Mégarbane
Bruno Mégarbane
LJLuc Marie Joly
Luc Marie Joly
SCSylvie Chevret
Sylvie Chevret
EAElie Azoulay
Elie Azoulay
There is a need for close communication with relatives of patients dying in the intensive care unit (ICU). We evaluated a format that included a proactive end-of-life conference and a brochure to see whether it could lessen the effects of bereavement.

14 July 2016 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
SGStéphane Gaudry
Stéphane Gaudry
DHDavid Hajage
David Hajage
FSFréderique Schortgen
Fréderique Schortgen
LMLaurent Martin-Lefevre
Laurent Martin-Lefevre
BPBertrand Pons
Bertrand Pons
DDDidier Dreyfuss
Didier Dreyfuss
The timing of renal-replacement therapy in critically ill patients who have acute kidney injury but no potentially life-threatening complication directly related to renal failure is a subject of debate.

1 March 2018 in New England Journal of Medicine
Verified
Journal Article
Closed access
DAdjillali Annane
djillali Annane
ARAlain Renault
Alain Renault
CBChristian Brun-Buisson
Christian Brun-Buisson
Bruno MégarbaneBruno Mégarbane
Bruno Mégarbane
JQJean-Pierre Quenot
Jean-Pierre Quenot
EBEric Bellissant
Eric Bellissant
Septic shock is characterized by dysregulation of the host response to infection, with circulatory, cellular, and metabolic abnormalities. We hypothesized that therapy with hydrocortisone plus fludrocortisone or with drotrecogin alfa (activated), which can modulate the host response, would improve the clinical outcomes of patients with septic shock.

24 September 2015 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
JPJean-Jacques Parienti
Jean-Jacques Parienti
Nicolas MongardonNicolas Mongardon
Nicolas Mongardon
Bruno MégarbaneBruno Mégarbane
Bruno Mégarbane
JMJean-Paul Mira
Jean-Paul Mira
PKPierre Kalfon
Pierre Kalfon
DCDamien du Cheyron
Damien du Cheyron
Three anatomical sites are commonly used to insert central venous catheters, but insertion at each site has the potential for major complications.

1 January 2021 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
OHOlivier Hermine
Olivier Hermine
XMXavier Mariette
Xavier Mariette
PTPierre-Louis Tharaux
Pierre-Louis Tharaux
MRMatthieu Resche-Rigon
Matthieu Resche-Rigon
RPRaphaël Porcher
Raphaël Porcher
SRSophie Renet
Sophie Renet
Coronavirus disease 2019 (COVID-19) is a respiratory disease induced by a novel coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) causing substantial morbidity and mortality.1-4 Most people with COVID-19 have only mild or uncomplicated symptoms, but approximately 10% to 15% have moderate or severe disease that requires hospitalization and oxygen support, and 3% to 5% require admission to an intensive care unit (ICU).5 In severe cases, COVID-19 can be complicated by acute respiratory distress syndrome (ARDS). Older age, male sex, and comorbid diseases are risk factors for death.6-8